LINC00709: A Drug Target / Disease Biomarker (G100507163)

Target Name: LINC00709

NCBI ID: G100507163

LINC00709

Other Name(s): long intergenic non-protein coding RNA 709 | Long intergenic non-protein coding RNA 709

LINC00709: A Drug Target / Disease Biomarker

LINC00709 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is found in various tissues of the body, including the brain, heart, liver, and pancreas, and is involved in a wide range of cellular processes.

One of the most promising aspects of LINC00709 is its potential as a drug target. LINC00709 has been shown to play a role in a variety of physiological processes, including cell signaling, metabolism, and inflammation. It is also known to interact with a variety of proteins, including the protein known as PDGF-BB.

In addition to its potential as a drug target, LINC00709 has also been identified as a potential biomarker. The use of RNA molecules as biomarkers has become increasingly popular in recent years, as it allows for the detection and quantification of small changes in gene expression levels.

One of the reasons for the popularity of RNA-based biomarkers is their ability to detect changes in gene expression that occur at the gene level, rather than at the level of the entire organism. This allows for more precise and accurate measurements of changes in gene expression.

In the case of LINC00709, its potential as a drug target and biomarker has been the subject of extensive research in recent years. Studies have shown that LINC00709 can be effectively targeted with small molecules, which has led to the potential for its use as a drug.

Additionally, LINC00709 has also been shown to be involved in a variety of cellular processes that are relevant to a number of diseases, including cancer, cardiovascular disease, and neurodegenerative diseases. This has further fueled interest in its potential as a drug target and biomarker.

In conclusion, LINC00709 is a promising drug target and biomarker that has the potential to revolutionize our understanding of a wide range of diseases. Further research is needed to fully understand its role and potential as a drug.

Protein Name: Long Intergenic Non-protein Coding RNA 709

The "LINC00709 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00709 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets